616 related articles for article (PubMed ID: 31099266)
1.
Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
[TBL] [Abstract][Full Text] [Related]
2. CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells.
Bellec J; Bacchetta M; Losa D; Anegon I; Chanson M; Nguyen TH
Curr Gene Ther; 2015; 15(5):447-59. PubMed ID: 26264708
[TBL] [Abstract][Full Text] [Related]
3. TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy.
Xia E; Zhang Y; Cao H; Li J; Duan R; Hu J
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30641980
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells.
Yan Z; Vorhies K; Feng Z; Park SY; Choi SH; Zhang Y; Winter M; Sun X; Engelhardt JF
Hum Gene Ther; 2022 Oct; 33(19-20):1023-1036. PubMed ID: 35686451
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
[TBL] [Abstract][Full Text] [Related]
6. Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus.
Cooney AL; Singh BK; Loza LM; Thornell IM; Hippee CE; Powers LS; Ostedgaard LS; Meyerholz DK; Wohlford-Lenane C; Stoltz DA; B McCray P; Sinn PL
Nucleic Acids Res; 2018 Oct; 46(18):9591-9600. PubMed ID: 30165523
[TBL] [Abstract][Full Text] [Related]
7. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction.
Xia E; Duan R; Shi F; Seigel KE; Grasemann H; Hu J
Mol Ther Nucleic Acids; 2018 Dec; 13():699-709. PubMed ID: 30513454
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model.
Potash AE; Wallen TJ; Karp PH; Ernst S; Moninger TO; Gansemer ND; Stoltz DA; Zabner J; Chang EH
Mol Ther; 2013 May; 21(5):947-53. PubMed ID: 23511247
[TBL] [Abstract][Full Text] [Related]
11. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
12. Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus.
Vaidyanathan S; Baik R; Chen L; Bravo DT; Suarez CJ; Abazari SM; Salahudeen AA; Dudek AM; Teran CA; Davis TH; Lee CM; Bao G; Randell SH; Artandi SE; Wine JJ; Kuo CJ; Desai TJ; Nayak JV; Sellers ZM; Porteus MH
Mol Ther; 2022 Jan; 30(1):223-237. PubMed ID: 33794364
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
14. Transfer of the Cystic Fibrosis Transmembrane Conductance Regulator to Human Cystic Fibrosis Cells Mediated by Extracellular Vesicles.
Vituret C; Gallay K; Confort MP; Ftaich N; Matei CI; Archer F; Ronfort C; Mornex JF; Chanson M; Di Pietro A; Boulanger P; Hong SS
Hum Gene Ther; 2016 Feb; 27(2):166-83. PubMed ID: 26886833
[TBL] [Abstract][Full Text] [Related]
15. Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis.
King NE; Suzuki S; Barillà C; Hawkins FJ; Randell SH; Reynolds SD; Stripp BR; Davis BR
Hum Gene Ther; 2020 Sep; 31(17-18):956-972. PubMed ID: 32741223
[TBL] [Abstract][Full Text] [Related]
16. Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy.
Bandara RA; Chen ZR; Hu J
Cell Biosci; 2021 Jul; 11(1):145. PubMed ID: 34301308
[TBL] [Abstract][Full Text] [Related]
17. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.
Schneider-Futschik EK
Gene Ther; 2019 Sep; 26(9):354-362. PubMed ID: 31300729
[TBL] [Abstract][Full Text] [Related]
18. Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models.
Wei T; Sun Y; Cheng Q; Chatterjee S; Traylor Z; Johnson LT; Coquelin ML; Wang J; Torres MJ; Lian X; Wang X; Xiao Y; Hodges CA; Siegwart DJ
Nat Commun; 2023 Nov; 14(1):7322. PubMed ID: 37951948
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
20. Overcoming Immunological Challenges to Helper-Dependent Adenoviral Vector-Mediated Long-Term
Cao H; Duan R; Hu J
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
